Exclusive interview for SPINOFF.COM with Dr. Robert Cucin, CEO of BioSculpture Technology, Inc. on the new generation of liposuction devices that treat obesity and diabetes
BioSculpture Technology, Inc. (“BST”) is a commercial stage medical device company steeped in the science of adipose tissue. BioSculpture addresses the liposuction and obesity markets with proprietary medical devices and saleable products. In 2013, the Company turned its focus from manufacturing power-assisted devices for the cosmetic liposuction market to developing a minimally invasive device and procedure for the treatment of obesity, metabolic syndrome and Type 2 diabetes mellitus. BST’s mission is to develop and manufacture medical devices and procedures for optimizing fat distribution and metabolism and for tissue aspiration and processing based on medical discoveries and state of the art advances, encompassing the bariatric market, the liposuction and body sculpting market, and the fat and adipocyte-derived stem cell processing and reinjection markets.